Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
James Kennedy, MD is Director of the Neuroscience Research Department, Section Head of the Psychiatric Neurogenetics lab and Head of the Tanenbaum Centre for Pharmacogenetics at the Centre for Addiction and Mental Health. Dr. Kennedy is Professor and Co-Director of the Brain and Therapeutics Division in the Department of Psychiatry at the University of Toronto. He is a member of the Collaborative Program in Neuroscience, and the Institute of Medical Science at the University.
Dr. Kennedy has training in three major areas: neuroscience, clinical psychiatry, and molecular genetics. My main research interest over the past 25 years has been the identification of susceptibility genes for psychiatric disorders. Dr. Kennedy sits on several neuroscience-related Advisory Boards including the Scientific Council of the Brain and Behavior Research Foundation (NARSAD), the OPTiMiSE schizophrenia trial and CRESTAR clozapine research group in Europe; International Society of Psychiatric Genetics (ISPG), 2014-2016 Schizophrenia International Research Society (SIRS) Program Committee, Assurex Scientific Advisory Board and Organizing Committee for Pharmacogenetics in Psychiatry. Over his 25 year career, Dr. Kennedy has published over 500 papers to date and is an active lecturer at numerous international conferences.
Lily R Aleksandrova, Renan P. Souza, Michael R. Bagby, David M. Casey, David C. Hodgins, Garry J. Smith, Rob J. Williams, Don P. Schopflocher, Rob T. Wood, Nady el-Guebaly, James L. Kennedy and Daniela S. S. Lobo
Review Article: J Addict Res Ther 2012, 3.1
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals